Newsroom
Category: School of Biomedical Sciences
October 9, 2018 • Graduate School Biomedical, North Texas Eye Research Institute, School of Biomedical Sciences
By Jan Jarvis Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness. Fortunately, blindness and eye damage can be prevented by suppressing the immune system and treating the disease with corticosteroids, said Sai Chavala, MD, Professor of Pharmacology and Neuroscience and Director of Translational Research at the North…
October 1, 2018 • Pharmacology and Neuroscience
By Jan Jarvis Army veteran R. J. Hillman was riding back to base from a 17-hour mission in Afghanistan when the blast from an IED sent shock waves radiating through his truck. Despite feeling dizzy, he immediately launched into his role as a medic. Later that night, his head ached. For the next 48 hours,…
September 26, 2018 • Education, School of Biomedical Sciences
By Alex Branch The ambivalence Sohail Siraj initially felt in college showed in the grades he earned his freshman and sophomore years at Texas A&M University. MS in Medical Sciences Learn more about admissions requirements, curriculum and application process. The Houston native wasn’t a bad student, but rather an unfocused one, unsure of what…
September 24, 2018 • Pharmacology and Neuroscience, Research
By Jan Jarvis By Jan Jarvis Every day, Kunlin Jin, MD, PhD, drinks five cups of green tea, three in the morning and two in the afternoon. Brewed from the unfermented plant, the tea has been touted for its anti-aging and longevity benefits. “It should be very good for your health,” said Dr. Jin,…
September 13, 2018 • Graduate School Biomedical, North Texas Eye Research Institute, School of Biomedical Sciences
By Jan Jarvis In 1998, a team of researchers that included Abe Clark, PhD, won worldwide recognition for its discovery of the first gene that causes glaucoma. Two decades later, the same team has found a possible treatment for this blinding eye disease. “We’ve gone from discovering the first glaucoma gene to finding a way…
September 12, 2018 • College of Pharmacy, School of Biomedical Sciences
By Jan Jarvis One drug treats hospital-acquired bacterial pneumonia. Another treats complicated intra-abdominal infections. And a third treats skin infections. These are among the many drugs that Jerry Simecka, PhD, has evaluated as part of the discovery process since establishing the Pre-Clinical Services group at UNT Health Science Center a decade ago. The successful…
August 23, 2018 • Community, Geriatrics, Pharmacology and Neuroscience One Pill Kills
One week – that’s how long it can take for a prescription pain killer to turn into an addiction to opioids. Patients believe opioids – a class of pain-killing drugs that can produce morphine-like effects – are safe and effective because their physician prescribed them, said Annesha White, PharmD, PhD, Associate Professor of Pharmacotherapy…
June 11, 2018 • Pharmacology and Neuroscience, Research, School of Biomedical Sciences
ByJan Jarvis For many of the 6.5 million people who live with heart failure, developing water retention related to their disease will decrease their chances of survival. Although many patients with water retention are treated with diuretics, it is not known why they develop the condition, said Tom Cunningham, PhD, Regents Professor of Physiology…
May 10, 2018 • Pharmacology and Neuroscience
By Jan Jarvis Since 2000, Dr. Rozalyn Anderson has studied aging and how calorie restriction helps monkeys live longer, healthier lives. What she has found is monkeys who eat less than their peers get fewer diseases of aging, such as cancer and cardiovascular disease. “A smaller body means a longer life and greater health,”…
April 11, 2018 • Pharmacology and Neuroscience, Research
By Raul Vintimilla, Department of Pharmacology and Neuroscience I had earned my medical degree and finished a three-year hospital residency in Cuenca, Ecuador when I decided to move my family to the United States. I had discovered during my training that clinical care was not my passion — research was. And the United States…
Social media